Apogee Therapeutics, Inc. Common Stock (APGE) — Defensive Interval Ratio
Apogee Therapeutics, Inc. Common Stock (APGE) has a Defensive Interval Ratio of 7830 days as of December 2025. Defensive assets of $598.64 Million (cash $-, short-term investments $598.64 Million, receivables $-) cover 7830 days of daily cash needs of $76.45K/day. Check tangible equity quality of Apogee Therapeutics, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Apogee Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Apogee Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 7830 days, meaning defensive assets of $598.64 Million can fund 7830 days of operations without new revenue. Also explore net asset momentum of Apogee Therapeutics, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Apogee Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Apogee Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Apogee Therapeutics, Inc. Common Stock.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 7830 days | $598.64 Million | $76.45K/day | $- | $598.64 Million | ▲ +2928 days |
| 2024 | 4902 days | $383.56 Million | $78.25K/day | $- | $378.86 Million | ▼ -40 days |
| 2023 | 4942 days | $278.36 Million | $56.32K/day | $- | $277.14 Million | ▲ +4942 days |
| 2022 | 0 days | $0.00 | $27.34K/day | $- | $0.00 | — |